IMPORTANCE Despite secondary prevention strategies with proven efficacy, recurrent stroke rates remain high, particularly in racial/ethnic minority populations who are disproportionately affected by stroke.
A pproximately 200 000 of the 800 000 stroke events occurring annually in the United States are recurrent events. 1 Compared with incident strokes, recurrent events are disproportionately fatal, disabling, and impose a high financial burden on patients, families, and the health care system. 2-4 Individuals who have had an incident stroke have up to a 30% probability of having another event within 5 years, 5 and rates of recurrence are significant even among those with mild stroke and transient ischemic attack (TIA) who also have significant vascular risk factor profiles. 6,7 Recurrent events disproportionately affect African American and Hispanic individuals; they are 2 to 3 times more likely to experience stroke and experience higher stroke-related mortality compared with non-Hispanic white individuals.
8-12
While clinical evidence strongly supports the effectiveness of improving health behaviors (eg, medication adherence) and modifying vascular risk factors (eg, blood pressure [BP] reduction) to reduce recurrent events, 13 secondary stroke prevention remains elusive. Within 1 year of hospital discharge, up to one-third of patients are not adherent to prescribed medications. 14 Patients with mild stroke and TIA, in particular, may underestimate risk of recurrence owing to mild or resolved deficits. 15 There are also persistent racial/ ethnic disparities in secondary prevention, largely due to cultural and behavioral factors not addressed in standard prevention modalities and poor integration into community resources.
11,16-18
A number of previous structural and educational interventions have targeted BP control in secondary stroke prevention. Structural interventions have focused on implementation of health system strategies to ensure patients are discharged appropriately and receive adequate follow-up care 19, 20 ; however, most tested interventions have not effectively addressed issues relevant to low socioeconomic and diverse populations. Previous work strongly suggests the context of behavior change plays an important role in development of optimal prevention strategies. 6, 17, 21 To this end, various trials have implemented educational interventions aimed at risk factor reduction with mixed results. 22, 23 Educational interventions to date have focused on teaching patients about their risk but have not coupled that with self-efficacy from a skillsbased approach. Further, few of these interventions have embraced culturally tailored strategies, which are critically needed to respond to health disparities. Discharge Educational Strategies for Reduction of Vascular Events (DESERVE) is an interactive, skills-based behavioral intervention delivered by a community health coordinator at hospital discharge, with 3 postdischarge reinforcement calls. DESERVE was a mandate from our stroke community as part of continued community engagement from a previous discharge stroke preparedness trial, the Stroke Warning Information and Faster Treatment (SWIFT) study. 6 Participants and family members in the SWIFT study requested skills and action steps to reduce risk; participants contributed to developing DESERVE intervention materials and are featured in patient narrative videos. The present study was a randomized clinical trial (RCT) that assessed the efficacy of DESERVE in a multiethnic cohort of patients with mild/moderate stroke/ TIA. The primary outcome was difference in systolic BP (SBP) reduction between predischarge and 12 months postdischarge.
Methods
Study Design, Setting, and Participants DESERVE was a 2-arm RCT with a 6-and 12-month follow-up. Between August 2012 and May 2016, 552 patients were prospectively enrolled from New York University Langone Medical Center, Icahn School of Medicine at Mount Sinai, Columbia University Medical Center, and Bellevue Hospital Center in New York City. A detailed description of the screening process and eligibility criteria has been published previously. 24 The trial protocol is available in the Supplement. All participants provided written informed consent. The study was approved by the institutional review boards of participating medical centers. Analyses began in May 2017.
Intervention
Participants were randomized, stratified by language and site, into intervention or usual care groups in a 1:1 ratio using a computerized permuted block randomization program. Prior to discharge, the intervention group engaged in an interactive educational session with a community health coordinator, someone hired from the underlying patient population and trained to do research; this position is similar to a community health worker or navigator. Participants also received a patientpaced workbook and video emphasizing 3 skills-based thematic areas: patient-physician communication, medication adherence, and accurate stroke risk perception with risk reduction skills ( Table 1) . Details of intervention development and materials are described elsewhere. 24 The intervention group also received follow-up calls from a coordinator at 72 hours, 1 month (typically immediately prior to neurology appointment), and 3 months to enhance strategies for patient-physician communication, clarify medication regimens, and provide social support to motivate behavior change. Participants randomized to the usual care group received standard stroke treatment as well
Key Points
Question What is the effect of a skills-based discharge intervention on blood pressure reduction among patients with mild/moderate stroke and transient ischemic attack?
Findings This randomized clinical trial of 552 patients found that a culturally tailored, skills-based discharge program with follow-up reinforcement led to a nonsignificant 2.5 mm Hg-greater systolic blood pressure reduction at 12 months postdischarge compared with usual care. There was a statistically significant 9.9 mm Hg-greater systolic blood pressure reduction in the intervention group compared with usual care among Hispanic individuals.
Meaning Further investigation may identify whether culturally tailored, skills-based education improves long-term vascular risk reduction for individuals who have had mild/moderate stroke/transient ischemic attack in different populations.
as American Heart Association stroke pamphlets in English or Spanish.
Study Procedures and Outcomes
Validated measures including vascular risk metrics (Table 1) were used at baseline and at 6 and 12 months postdischarge.
24
Race and Hispanic/Latino ethnicity were self-reported by participants by asking them to select from a list of US Census categories. Follow-up surveys and measures were conducted by trained research assistants blinded to intervention status. Every attempt was made by the study team to conduct follow-up surveys in person. If unable to complete in person, participants were interviewed over the telephone, and permission was obtained to request recent laboratory work from the participant's physician. We reviewed records for BP as well as secondary outcomes, including other risk factors and outcome events of stroke, myocardial infarction, or vascular death; adjudication of secondary outcomes is currently under way. If participants could not be reached by telephone, retention letters were sent and home visits were made. The primary study outcome was SBP reduction between baseline (predischarge) and 12 months postdischarge. Baseline BP was measured at least 48 hours poststroke up to 3 times by trained coordinators or research assistants using an automatic sphygmomanometer, following American Heart Association guidelines. 25 At 12-month follow-up, 120 BP measurements (25%) were done in person in the study office or participants' homes, 294 (62%) came from either clinic visits where our study staff met patients or abstracted medical records, 26 (5%) were self-reported, and 38 (8%) did not have a source recorded. The distribution of source of follow-up BP measurement did not differ significantly between trial arms. If participants could not be reached, we used the National Death Index to ascertain deaths and obtain cause of death; all other participants were considered lost to follow-up.
Statistical Analysis
Sample size calculations were based on a randomized pilot study of 50 patients with TIA/mild stroke, which demonstrated an 8-mm Hg reduction in SBP in the intervention vs usual care group. We then conducted power analysis using a lower 6-mm Hg estimate and an assumed variability of 23 mm Hg as seen in the pilot. Given 300 participants per group and α = .05, power was 89.1%. Mean reduction in SBP in the intent-to-treat population was compared between trial arms using linear regression models with 95% CI adjusted for study site and mixed-effects models using BP data at baseline and at 6-and 12-month follow-up. Secondary analyses were conducted to assess the effect of the intervention by race/ethnicity by stratifying all analyses by racial/ethnic group (non-Hispanic white, non-Hispanic black, and Hispanic). Non-Hispanic other was not included because it comprised a small and heterogeneous sample. In an additional exploratory analysis, the effect of the intervention by sex was evaluated. Although the study was not powered to detect differences in subgroup intervention effects, adjusted linear models with an interaction term were used to test statistical interaction between trial arm and race/ethnicity and between trial arm and sex. Within the intervention group, we also examined whether there was a dose-response relationship by number of follow-up reinforcement calls completed for the intervention response by comparing mean reduction in SBP by number of calls completed using t tests and analysis of variance. All analyses used SAS version 9.4 (SAS Institute), and statistical significance was determined where P was less than .05. All CIs are presented as nominal, ie, without adjustment for the multiplicity of tests performed.
Results

Recruitment and Follow-up
A total of 4166 participants were screened and 1083 (26%) were eligible for enrollment ( Figure 1 ). We screened a very large population owing to nonspecific symptoms that may be associated with mild stroke/TIA. We enrolled 552 patients, with 274 (49.6%) randomized to intervention and 278 (50.4%) to usual care. At 12-month follow-up, 13 participants (4.7%) in the intervention group and 14 (5.0%) in the usual care group were alive but unable to be reached to determine SBP levels. Median (interquartile range) duration of follow-up to measure SBP reduction in the study (not shown) was 13.8 (12.2-17.4) months and did not differ Table 2) . Mean National Institutes of Health Stroke Scale score indicated that strokes in this patient sample were generally mild. In both trial arms, approximately half of participants were women and born in the United States, and slightly less than half had a high school education or less and were married or living with a partner. Participants in both arms were roughly equally distributed across racial/ethnic groups. Approximately one-third of participants had a prior stroke or TIA, and most had a history of hypertension diagnosis and had overweight or obesity.
SBP Reduction Between Baseline and 12-Month Follow-up
Mean (SD) reduction in SBP between baseline and 12-month follow-up was 7.0 (25.5) mm Hg among intervention and 4.3 (23.4) mm Hg among usual care participants (Table 3 and Figure 2 ). In adjusted models, no significant difference in reduction in SBP was observed between groups (β = 2.5 mm Hg; 95% CI, −1.9 to 6.9). However, the intervention arm had an almost 10 mm Hg-greater mean reduction in SBP compared with usual care among Hispanic participants (β = 9.9; 95% CI, 1.8-18.0). An additional analysis of the primary end point, using a random-effects model that also included the 6-month SBP assessment, also showed no overall difference in SBP reduction but a significant effect for the intervention among Hispanic individuals (estimated mean difference at 12 months = 9.4 mm Hg; 95% CI, 1.7-17.1). There were no significant differences in mean reduction of SBP between trial arms among non-Hispanic white individuals (β = 3.3; 95% CI, −4.1 to 10.7) and non-Hispanic black participants (β = −1.6; 95% CI, −10.1 to 6.8). The interaction term between intervention arm and race/ethnicity was not significant (F = 1.84; P = .16). Among men, the intervention arm had 5.5 mm Hg-greater mean reduction in SBP (95% CI, −0.7 to 11.8) compared with the usual care arm, but this difference was not statistically significant. There was no difference noted among women (β = -0.4; 95% CI, −6.5 to 5.8). The interaction term for intervention arm and sex was not significant (t =1.37 ;P = .17). To address the statistically significant difference in mean age between trial arms at baseline, we conducted sensitivity analyses to also adjust for age in linear regression models and found similar results. Finally, we examined whether there was a dose-response relationship in the intervention group between participating in up to 3 follow-up calls and SBP reduction. Of those randomized to the intervention arm, two-thirds (184 [67.2%]) had 3 follow-up calls, 15.0% (n = 41) had 2 follow-up calls, 6.2% (n = 17) had 1 follow-up call, and 11.7% (n = 32) received no follow-up calls. We found that with each additional follow-up call, there appeared to be a greater mean reduction in SBP (1 call, 0.4 mm Hg; 2 calls, 6.1 mm Hg; 3 calls, 8.3 mm Hg; F =0.77;P = .51). Also, those who received the full intervention (all 3 calls) had a greater reduction compared with those who received partial intervention (<3 calls) (8.3 vs 3.5 mm Hg, t = −1.32; P = .19). However, these differences were not statistically significant.
Discussion
The DESERVE trial focused on a novel skills-based approach to vascular risk reduction and is also one of the first stroke prevention RCTs to examine differences in behaviors and outcomes by race/ethnicity. At 12-month follow-up, the intervention group had a nonsignificant 2.5 mm Hg-greater mean SBP reduction compared with usual care (95% CI, −1.9 to 6.9). Although not powered to detect differences in subgroup analysis, we found that Hispanic participants in the intervention group had a clinically and statistically significant 9.9 mm Hg-greater SBP reduction compared with usual care (95% CI, 1. There appears to be a different pattern of response to the intervention and usual care across racial/ethnic groups (Table 3) . Among Hispanic individuals, there was a large reduction in SBP in the intervention group and a small increase in usual care. Similar to Hispanic individuals, nonHispanic white individuals experienced a large reduction in SBP in the intervention group, but they also had a moderate reduction in BP in usual care. The pattern is different in non- a Adjusted for study site; interaction between trial arm and race/ethnicity, P = .16; interaction between trial arm and sex, P = .17.
b Difference in mean reduction by race/ethnicity in overall sample, P = .22; by sex, P =.02.
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Hispanic black individuals, with the usual care and intervention groups both experiencing moderate decreases in BP. We speculate this differential response may be due to a number of factors, including differential uptake or use of the intervention, different social network structures, and poorer access to stroke resources among Hispanic individuals.
30
Hispanic individuals in the United States have low stroke-specific health literacy and are less likely to be aware of their hypertension status, adhere to cardiovascular disease medications, and have controlled hypertension compared with non-Hispanic white individuals. [31] [32] [33] [34] [35] [36] [37] [38] The effect of the DESERVE intervention on Hispanic individuals may be due to specific components of the intervention design that address some of these gaps. The intervention included English and Spanish materials and bilingual coordinators delivering the intervention who were ethnically concordant with participants whenever possible. Among Hispanic individuals, our culturally tailored stroke survivorship narrative video developed in partnership with community members framed recovery in the context of faith and spirituality, in contrast to the video for African American individuals, which presented recovery after stroke as a matter of selfdetermination. Importantly, DESERVE educational materials also focused on building patient-physician communication skills, which are a documented barrier to care among Hispanic individuals.
39-43
Previously, several structural interventions have tested models of collaborative and coordinated care for optimizing secondary stroke prevention.
19,20,44,45 While some proved effective, they were mainly conducted in ethnically homogenous populations and within single-payer health care systems; it is unclear whether such approaches would be feasible in the United States where health care differentials exist. In contrast to these structural approaches to secondary prevention, other strategies focused on improving patients' knowledge through education. These interventions have taken various forms, including education at discharge alone, education with reinforcement postdischarge, and ongoing BP monitoring.
22,23,46,47
Most tested educational interventions use highly trained staff, such as nurses, and involve extensive time and effort, a model that is not sustainable given the high cost of health care. DESERVE builds on past interventions in a number of significant ways. While previous educational interventions have largely focused on changing patients' risk factor knowledge, DESERVE is one of the first interventions to take a skills-based approach. The intervention was designed with community input following the SWIFT trial and uses the extended parallel process model to build on the teachable moment of stroke diagnosis. 48 Using the extended parallel process model, intervention participants' perceived risk and perceived efficacy are evaluated to build skills for sustained behavior change. DESERVE focused on developing strategies and tools that empower patients to promote active communication with their physicians, reduce barriers to medical adherence, and enhance vascular health. For example, we helped participants identify areas of confusion and create a checklist of questions for their physicians, and we reinforced these skills prior to physician visits through telephone calls.
Optimizing skills in this way may be more effective in achieving control of risk factors. 49 By training patients to take ownership of controlling risk factors, DESERVE allows the process to be sustainable beyond the health care system. Additionally, unlike most secondary prevention interventions to date and to our knowledge, our materials were health literate and created in partnership with community members. Health literacy has particular relevance for individuals with chronic illness because they need to manage their disease over an indefinite period of time.
Strengths and Limitations
This study had several strengths. First, by using an RCT design, we were able to rigorously evaluate the efficacy of our intervention. Second, through using bilingual coordinators and working with community partners, we were able to enroll and engage patients with stroke/TIA who are often underrepresented in RCTs. 50 Our diverse study sample also allows us to generalize our results to other urban settings. Additionally, the study benefited from a high retention rate, which minimized the potential for selection bias, which can be a particular threat to prospective studies. This study also had several important limitations. First, as part of usual care in our trial, we ensured that every participant received health literate and linguistically appropriate educational materials, which may not be a consistent practice in real-world settings. This enhancement may have attenuated the effect of the intervention. Second, owing to the difficulty of scheduling appointments, we were not able to obtain in-person follow-up BP measurements for some of our participants and had to rely instead on physician records. These measurements may not have been taken using the same standardized instruments and procedures as indicated in our study protocol. However, the research assistant collecting measurements from physicians was blinded to intervention status, so any misclassification of the outcome would be nondifferential leading to underestimated results. Additionally, the distribution of source of follow-up BP measurement did not differ significantly between trial arms in the overall sample or between trial arms by race/ethnicity, reducing potential for bias.
Conclusions
While the overall trial demonstrated SBP reductions in both arms leading to a nonsignificant intervention effect, DESERVE results suggest that culturally tailored, skills-based education with follow-up reinforcement may lead to clinically meaningful BP reduction among certain racial/ethnic populations 1 year poststroke. This is important as few behavioral intervention studies in individuals who have had stroke have reported significant longterm differences in vascular risk reduction, and fewer have focused on a skills-based approach. Further, DESERVE is one of the first interventions potentially demonstrating capacity to decrease racial/ethnic disparities in stroke risk reduction. Our results suggest that culturally tailored, skills-based interventions may be more useful than knowledge-focused interventions in achieving sustained vascular risk reduction and addressing racial/ethnic disparities in stroke; however, these findings should be tested in future studies.
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The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. after-affects also stay in the hospital for a shorter period of time, and leave without enough 4 information about their risk for another stroke. Additionally, mild stroke and TIA patients often do 5 not follow-up with neurologists after they leave the hospital. DESERVE is a discharge education 6 study using community health workers to enroll and randomly assign 600 subjects diagnosed with 7 TIA or mild stroke to either risk factor education or standard care. Those patients assigned to 8 education will receive stroke preparedness education plus risk factor reduction education, and help 9 accessing follow up care with community health workers. Those patients assigned to standard 10 care will receive written/video information and stroke preparedness education. This protocol will 11 evaluate the effectiveness of this intervention to reduce blood pressure, and individual stroke risk 12 factors and future stroke risk. Additionally, we will evaluate the ability of the these strategies to 13 conduct education to affect positive change in taking medications as directed, stroke knowledge 6 14 months and 12 months after hospital admission, attendance at follow-up health care appointments, 15 and cost-effectiveness. After 1 year participants will be followed quarterly for up to 3 years to 16 track events. 17
1) Objectives
18
Participants randomized to the DESERVE intervention, which is focused on increasing risk knowledge, 19 improving medication adherence, improving patient-physician communication and linking to medical 20 resources, will have significantly decreased systolic blood pressure, lower HbA1c and decreased risk 21 factor profile compared to those randomized to enhanced usual care at 12 months post-discharge. 22 23
2) Background
24
The burden of stroke and its modifiable risk factors disproportionately affects minority populations, and 25 secondary stroke prevention strategies in these populations have been suboptimal. TIA and mild stroke 26 (both Ischemic and Hemorrhagic) patients with limited deficits additionally have short hospital stays, 27 inaccurate perceptions of their vascular risk for recurrent events, and poor adherence rates to follow-up 28 plans. DESERVE is a multi-level discharge intervention using community health workers to enroll and 29 randomize 600 subjects diagnosed with TIA or mild ischemic stroke or mild intracerebral hemorrhage 30 (ICH). Subjects randomized to intervention will receive stroke preparedness education plus risk factor 31 reduction education, and health care linkage, as compared with usual care (written information and stroke 32 preparedness education). This protocol will evaluate the effectiveness of this intervention to reduce blood 33 pressure, and therefore vascular risk. Additionally, we will evaluate the efficacy of the intervention to 34 affect positive change in medical adherence and stroke knowledge at 6 months and 12 months post-35 admission, follow-up health care adherence, and cost-effectiveness measures. 36 37 
3) Setting of the Human Research
56
To target the most appropriate mild IS/ICH and TIA survivors for participation in this proposal, we will 57 focus on survivors with mild stroke and TIA, excluding those whose stroke deficits are severe enough to 58 warrant discharge to a nursing home or to require 24-hour care. We have a demonstrated ability to enroll 59 600 participants in 3 years with one year follow-up. Figure 1 demonstrates 
70
Cases of TIA and stroke will be identified with a comprehensive prospective case surveillance system that 71 has been ongoing for 15 years at CUMC and will be adapted for recruitment at NYU Medical Center and 72
Bellevue. As documented in the literature, our stroke surveillance methodology includes daily screening 73 of all admissions, discharges, and head CT scan logs at NYU Medical Center and Bellevue Hospital. 74
Patients diagnosed with stroke, TIA and a variety of other neurological syndromes including aphasia, 75 hemiparesis, sensory changes, vertigo, and dysarthria, among others, are screened and the cases discussed 76 with study neurologists and fellows to confirm eligibility. Eligibility will be based on a clinical definition 77 of IS/ICH: focal neurologic deficits consistent with a vascular territory of the brain; and TIA will be 78 defined as stroke symptoms lasting <24 hours. After eligibility is confirmed, and with the attending 79 physician's permission to approach the patient, the Health Educators will obtain written informed consent 80 from the patient. We will also recruit acute TIA patients seen in Stroke clinic and Stroke Faculty Practices 81 at NYU and Bellevue that will not be admitted to the hospital. These patients will only be recruited 82 through physician or Nurse Practitioner referral. If an acute TIA patient is seen in clinic, their provider 83 will contact a member of the study team. The study team will then approach the patient in clinic with the 84 provider's approval. 85 86 After informed consent is obtained, the study team will meet with the mild IS/ICH or TIA participant in 150 the hospital to conduct baseline evaluations for the participant. Participants will be asked if they want 151 family and friends involved in the study and will be stratified according to whether family and friends are 152 involved as well as undergo a stratified randomization based on language to ensure a balanced distribution 153 of English and Spanish in each of the study arms. The study statistician will provide the randomization 154 scheme and use a randomization block scheme stratified by primary language. The SWIFT stroke 155 preparedness module will be given to all participants prior to discharge. After the usual discharge 156 instructions are provided by the physician and nurse practitioner, the health educator will provide each 157 participant with health literature information which will include American Heart Association and National 158
b) Inclusion and Exclusion Criteria
Stroke Association brochures about mild IS/ICH and TIA and risk factors, which will offer answers to 159 frequently asked questions as well as provide information on local resources and stroke support groups. 160
All participants will receive a card with the time, location and contact information for a follow-up 161 appointment at the Neurology Clinic, stroke subspecialty, to occur within one month of discharge. For 162 those subjects randomized to intervention, discharge will also be a time at which CHWs will review some 163 basic stroke risk information, and go over the discharge and aftercare instruction including medications, 164
and answer any questions that may arise. All participants will be asked to confirm their follow up visit 165 appointment with the Neurology Clinic. 166 167
Data will be collected through in-person interviews (attached to submission), measurements of 168 anthropometric indices, systolic and diastolic blood pressures, and neurological examination. Data will be 169 collected at baseline, 6 months and 12 months. All participants will receive appointments for in-person 170 evaluations with study staff at 6 months and 12 months. All data will be collected in English or Spanish 171 through interview of the participants by trained bilingual Health Educators, using standardized data 172 collection instruments, review of the medical records, and physical measurement of blood pressure. 173 174
Biomarker Collection: We will expand on the data described above by the collection and analyses of 175 biomarkers of cardiovascular disease risk for the entire sample. The proposed biomarker data and 176 extended prospective design will enable us to conduct in-depth, longitudinal investigations of social 177 determinants of cardiovascular disease and underlying pathways, tracing factors at multiple levels of 178 influence -environmental, social, behavioral, biological -to medically-confirmed cardiovascular disease 179 endpoints. There are two reasons we chose the following biomarkers to explore causal mechanisms 180 between social determinants and vascular health outcomes. First, the literature identifies critical 181 biomarkers with a high likelihood of linking social determinants and vascular health. Second, in an 182 attempt to embrace the nature of disparities, we have chosen to focus on Metabolic Syndrome and 183
Neurendocrine markers. The capture of biological specimens for biomarker analysis will be through 184 saliva. Methodology for collection of saliva. Saliva will be collected through a Passive Drool 185 methodology. This is a cost-effective method to collect whole saliva by passive drool into a small vial. 186
Passive drool is highly recommended because it is approved for use with almost all analytes, unlike 187 absorbent devices, which sometimes causes interference in immunoassays. This method uses high-quality, 188 tightly sealed polypropylene vials, to avoid problems with analyte retention or introduction of 189 contaminants. Prior to Saliva Collection, research participants will rinse their mouth with water 10 190 minutes. Participants will be given one straw piece and one cryovial and instructed to allow saliva to pool 191 Blood pressure will be measured three times using a calibrated aneroid sphygmomanometer at discharge 209 by trained health educators. After five minutes of relative immobility in a sitting position, the first blood 210 pressure measurement will be recorded. At the end of the interview, a second BP measurement will be 211 recorded. In subjects with blood pressure recordings discrepant by more than 10 mm Hg, a third measure 212 will be obtained. HTN will be captured using ATP III criteria and defined as a systolic blood pressure 213 recording greater than 130 mm Hg, or a diastolic blood pressure recording greater than 85 mm Hg based 214 on the average of the two blood pressure measurements. Definite HTN established by patient self-report 215 of history of HTN or anti-hypertensive use will also be recorded. Height, weight, waist and hip 216 circumference will be measured and BMI calculated. In participates with history of diabetes, we will also 217 record HbA1c. 218 219
The Morisky Adherence scale and pill count will be used to measure adherence with medication regimen. 220 221
All stroke and TIA patients should be seen for neurological follow-up within the first month post 222 discharge. Appointments will be made for all participants at baseline. Through phone calls and 223 surveillance we will track follow-up appointment adherence. 224 225
Self-perceived risk perception will be estimated using a general estimate established from relevant 226 literature on the topic at 30% as well as the NOMAS 7 scale for actual risk. 227 228
At baseline, study personnel will collect data related to social resources, health care access, insurance 229 type, health literacy, social support, and readiness to change. 230 231
Evaluations will include an assessment of depression (Centers for Epidemiological Studies-Depression 232 Scale) at baseline and at 6 month and 12 month follow-up. The CES-D will be administered at the 233 discretion of the study team at any point during the study when symptoms of depression are suspected or 234 observed. 235 236
In order to control for the Hawthorne Effect, the study team will call all participants at 2 weeks post-237 discharge, including those randomized to enhanced usual care, to see how they are feeling and capture any 238 outcome events. These calls will provide a match to the human interaction that the intervention group 239 receives, although enhanced usual care participants will not receive the intervention components or calls. 240
Vascular risk factor modification will remain a part of standard medical care and the responsibility of 241 each patient's PCP and Neurology clinic physician, as it would, had the patient not enrolled in this study. 242 We recognize that participation in a study and receipt of such physiologic measurements may be an 243 intervention in and of itself, and usual-care arm subjects may be slightly more motivated than usual to 244 alter their own risk factors. However, we do not see an ethical alternative, as we feel obligated to report 245 our findings to the subjects regarding their personal risk for future strokes. All participants will be 246 encouraged to call the study team with any questions. 247 248
Finally, we will request medical records for the study period for all participants, to confirm our informal 249 record of all medical attention received during the study period. 
259
the intent-to-treat principle. That is, in order to preserve the probability space created by the randomized 260 allocation of subjects to interventions, all subjects must be analyzed, and in the intervention arms to 261 which they were initially assigned, irrespective of subsequent events or behavior. The randomization 262 scheme ensures that the group assignment is independent of other study variables, which makes 263 primary analyses valid even when some of the subject's or community's characteristics are not balanced 264 in the two groups. Protocol violations, crossovers, subjects who are lost, and so forth, do not alter the 265 intent-to-treat analysis. All the models for secondary analyses are declared specifically (specified a 266 priori) and we will conduct diagnostic for the goodness of fit for each involved models including linear 
282
The primary hypothesis is to test whether the change in systolic blood pressure (SBP) at 6 months 283 follow-up is the same for the intervention group and the enhanced usual care group. Primary outcome is 284 the change in SBP levels between baseline and at 6 month post-intervention. We note here that post-285 intervention SBP level without considering pre-intervention SBP level could be a valid primary outcome 286 due to randomization, but we choose the change in SBP as primary outcome since the change has a 287 smaller variance than the post-intervention SBP level. It can be easily verified that the variance of the 288 change is smaller than the post-intervention measurement when the correlation between the pre-and 289 post-intervention levels is greater than 0.5. Data from the NOMAS group and SWIFT group of community 290 participants and mild IS/TIA patients demonstrate that such correlation is 0.7. As described earlier, we
291
invoke Intent-to-treat analysis using t-test for two samples and this will be our confirmatory analysis.
292
As secondary analyses for the primary aim, we will conduct linear regression analysis using the 293 change as an outcome and intervention assignment as independent variable while using language
294
(stratifying variable), social support, race-ethnicity, BMI, alcohol intake, insurance status, education and 295 marital status as covariates to evaluate the effect of intervention adjusting for those covariates. We will 
305
We will also conduct repeated measures analysis using the changes in systolic blood pressure at 1, 6 306 months s as a vector of outcome. We will fit Generalized Estimating Equation (GEE) model using the 307 intervention indicator, time, and interaction between the intervention indicator and time as covariates.
308
We will first jointly test whether the coefficients for intervention indicator and the interaction term are 309 zero. If the interaction term between the intervention and time is not significant, we will report an overall 310 intervention effect over time. We will also add covariates such as using social support, race-ethnicity,
311
BMI, , insurance status, education and marital status to evaluate the adjusted effect of intervention over 312 time.
313
Secondary Analysis AIM 1. The first secondary aim is to evaluate the efficacy of the DESERVE 314 intervention on medication adherence by comparing the pill count adherence rates at 6 and 12 month.
315
Two outcomes will be used: pill counts; and adherence on the Morisky Adherence Scale. For agent pill 316 counts, we will fit Poisson regression with log link function using pill counts as outcome, intervention 317 indicator, race-ethnicity, gender, insurance status, previous stroke scale, education and age as 318 covariates, and logarithm of the number of total pills that a subject should take as an offset. For the
319
Morisky Adherence Scale, we will use linear regression with the score at 6 and 12 month as outcome 320 and intervention, race-ethnicity, gender, insurance status, previous stroke scale, education and age as 321 covariates.
322
AIM 2. Outcome of the analysis is the binary indicator whether the subject has right perception of 323 recurrent event. We classify that the subject has correct stroke risk knowledge when the subject answer 324 the risk of recurrence is between 25-35%. We will conduct logistic regression analysis with the binary 325 indicator of correct stroke knowledge as outcome and intervention with race-ethnicity, gender, insurance 326 education and age. 
350
identify all resources used in DESERVE (program resources, participant resources, direct health care 351 resources), 2) quantify these resources used, and 3) assign per unit costs to each of these resources.
352
We will then combine our data on use with our proxies of per unit costs. algorithms that provide 128-bit encryption capability. Most importantly, data encryption-decryption is 389 integrated within the application logic. The encryption process is automatic, and completely transparent to 390 the end user. Typically a secret key comprising of a string of characters is generated and stored in a secure 391 location on the application server. 392
Audit trail and FDA 21CRF Part 11 compliance. The protocol for data flow management and data 393 security standards meets the requirements of current FDA 21CRF Part 11 regulations for clinical trials. 394
Database connections, user logins, and data changes are stored in a data dictionary table. In particular, the 395 system server keeps a log of each submitted set of changes to the data as a separate transaction along with 396 the identifier of the user who made the change and the date and time the change was made. This permits 397 tracking of all data modifications and has the capability of restoring the database to its status at any point 398 in time. An audit trail, available to authorized users, can be viewed and printed. 399
Data download. Authenticated users can download data from any internet connected computer. Data 400 extraction is automatic and conforms to standard statistical software packages, like SAS and SPSS.
401
Data backup and disaster recovery planning. We have a highly redundant set of back-up procedures.
402
An automated backup is run every weekday in which each database and all associated forms, report-403 generating and retrieval programs are copied from the server to one of the local machines. Each night, a 404 programmed backup to a 24GB-capacity internal tape drive on the server copies the entire contents of the 405 server's hard drives to tape. A detailed disaster recovery document is maintained for each of our servers 406 with instructions for restoring the system to alternative hardware in the event of a complete system loss. 407
Web-based Tools for Project Management. Our team will establish state-of-the-art web-based 408 management tools, and will further develop any additional tools and features that will improve the 409 management of the clinical trials. These web-based tools and features will include: 1) Programmed 410
Reports providing updates to specified investigators and project coordinators with respect to: a) patient 411 accrual (randomization) and data completeness; b) site-specific schedules indicating subjects due for 412 follow-up examinations and/or telephone contacts; c) specified inconsistencies, missing information and 413 out-of-range values on data submitted for entry; 2) Facilitated and Secure Communication between the 414 coordinating center and the sites through Secure Socket Layer (SSL) technology wherein all data is 415 encrypted during transit; 3) Downloading of Key Documents for the conduct of each trial, including the 416 protocol, copies of the CRF, and summaries of key procedures, such as randomization and handling of 417 serious adverse events. Other web-based tools will be provided on an as-needed basis, depending on the 418 design and specific needs of each project. 419 Center. Data collection and management is site specific and will be handled according to 515 site regulations. Only di-identified data will be transferred between sites. Following the 516 completion of the data collection period (July 31, 2015), based on staffing, follow-up visits 517
i) Provisions to Monitor the Data to Ensure the Safety of Subjects
for study subjects will be conducted at the New York University Langone Medical Center 518 campus. Personal health information (PHI) may be transferred from another site 519 participating in the study to NYULMC. This PHI will be accessible only to authorized 520 study personnel for the purpose of contacting study subjects to complete study follow-up 521 visits. Dr. Boden-Albala will conduct biweekly meetings with the research team to review: 522 data management protocols; updates on transfer of data; debriefing on protocols; review of 523 QA of the dataset with monthly reports; managing intervention modules moved to DVD; 524 working with ED and Neurology; data analysis, and manuscript development. 525
16) Community-Based Participatory Research
526
This study including development of materials was the product of CBPR activities at 527
Columbia University Medical Center. 528
17) Sharing of Results with Subjects
529
Results of tests will be shared with subjects during follow up visits, and with subjects' 530 primary care provider if requested. 531 
18) External IRB Review History
